-
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
Journal： Oncology Reports
引用产品：anti-protein retinoblastoma (Rb) antibody()
ApplicationWB
IF3.417
SpeciesHuman
-
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
Journal： Oncology Reports
引用产品：anti-Bax antibody(BS6420/BS2583/MB62575)
ApplicationWB
IF3.417
SpeciesHuman
-
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
Journal： Oncology Reports
引用产品：anti-Bcl-2 antibody(BS65626/BS65629/BS90127)
ApplicationWB
IF3.417
SpeciesHuman
-
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
Journal： Oncology Reports
引用产品：anti-p21 antibody(BS65915)
ApplicationWB
IF3.417
SpeciesHuman
-
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
Journal： Oncology Reports
引用产品：anti-p53 antibody(BS6437)
ApplicationWB
IF3.417
SpeciesHuman
-
EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy
Journal： Oncology Reports
引用产品：anti-β-actin antibody(AP0060)
ApplicationWB
IF3.417
SpeciesHuman
-
Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition
Journal： Oncology Reports
引用产品：anti-GAPDH antibody(MB001)
ApplicationWB
IF3.417
SpeciesHuman,Mouse
-
Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition
Journal： Oncology Reports
引用产品：secondary antibodies()
ApplicationWB
IF3.417
SpeciesHuman,Mouse
-
Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
Journal： Oncology Reports
引用产品：anti-vimentin antibody()
ApplicationWB
IF3.417
SpeciesHuman
-
Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
Journal： Oncology Reports
引用产品：rabbit anti-E-cadherin antibody()
ApplicationWB,IF
IF3.417
SpeciesHuman
